Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:168-175
Published online before print December 12, 2002, doi: 10.1161/01.ATV.0000051384.43104.FC
Published online before print December 12, 2002, doi: 10.1161/01.ATV.0000051384.43104.FC
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 American Heart Association, Inc.
ATVB In Focus |
Endothelial Dysfunction
A Marker of Atherosclerotic Risk
From the Center for Coronary Physiology and Imaging (P.O.B., A.L.), Division of Cardiovascular Diseases, and the Division of Hypertension (L.A.L.), Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn.
Correspondence to Amir Lerman, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail lerman.amir{at}mayo.edu
Abstract
Endothelial dysfunction is a systemic disorder and a key variable in the pathogenesis of atherosclerosis and its complications. Current evidence suggests that endothelial status is not determined solely by the individual risk factor burden but rather, may be regarded as an integrated index of all atherogenic and atheroprotective factors present in an individual, including known as well as yet-unknown variables and genetic predisposition. Endothelial dysfunction reflects a vascular phenotype prone to atherogenesis and may therefore serve as a marker of the inherent atherosclerotic risk in an individual. In line with this hypothesis, dysfunction of either the coronary or peripheral vascular endothelium was shown to constitute an independent predictor of cardiovascular events, providing valuable prognostic information additional to that derived from conventional risk factor assessment. Interventions like risk factor modification and treatment with various drugs, including statins and angiotensin-converting enzyme inhibitors, may improve endothelial function and thereby, potentially prognosis. Hence, given its reversibility and granted the availability of a diagnostic tool to identify patients at risk and to control the efficacy of therapy in clinical practice, endothelial dysfunction may be an attractive primary target in the effort to optimize individualized therapeutic strategies to reduce cardiovascular morbidity and mortality.
Key Words: endothelial dysfunction • atherosclerosis • risk factor • cardiovascular event • prognosis
This article has been cited by other articles:
 |
|
 |
|
  M. Jensterle, M. Sebestjen, A. Janez, J. Prezelj, T. Kocjan, I. Keber, and M. Pfeifer Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome Eur. J. Endocrinol., October 1, 2008; 159(4): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Romualdi, B. Costantini, L. Selvaggi, M. Giuliani, F. Cristello, F. Macri, A. Bompiani, A. Lanzone, and M. Guido Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective Hum. Reprod., September 1, 2008; 23(9): 2127 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Thore, J. Stalhand, and M. Karlsson Toward a noninvasive subject-specific estimation of abdominal aortic pressure Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1156 - H1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kris-Etherton, F. B. Hu, E. Ros, and J. Sabate The Role of Tree Nuts and Peanuts in the Prevention of Coronary Heart Disease: Multiple Potential Mechanisms J. Nutr., September 1, 2008; 138(9): 1746S - 1751S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S S M Chen, A E Donald, C Storry, J P Halcox, P Bonhoeffer, and J E Deanfield Impact of aortic stenting on peripheral vascular function and daytime systolic blood pressure in adult coarctation Heart, July 1, 2008; 94(7): 919 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tamagawa, N. Bai, K. Morimoto, C. Gray, T. Mui, K. Yatera, X. Zhang, L. Xing, Y. Li, I. Laher, et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L79 - L85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Han, J. H. Bae, D. R. Holmes Jr, R. J. Lennon, E. Eeckhout, G. W. Barsness, C. S. Rihal, and A. Lerman Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis Eur. Heart J., June 1, 2008; 29(11): 1359 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C.-W. Ma, W.-Y. So, X. Yang, L. W.-L. Yu, A. P.-S. Kong, G. T.-C. Ko, C.-C. Chow, C. S. Cockram, J. C.-N. Chan, and P. C.-Y. Tong Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2045 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cheng, C. Daskalakis, and B. Falkner Original Research: Capillary rarefaction in treated and untreated hypertensive subjects Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 79 - 88. [Abstract] [PDF]
|
|
|
|
|
|
R. Rossi, A. Nuzzo, G. Origliani, and M. G. Modena Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 997 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Belizna, A Lartigue, J Favre, D Gilbert, F Tron, H Levesque, C Thuillez, and V Richard Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome? Lupus, March 1, 2008; 17(3): 185 - 194. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Terashima, P. K. Nguyen, G. D. Rubin, C. Iribarren, B. K. Courtney, A. S. Go, S. P. Fortmann, and M. V. McConnell Impaired Coronary Vasodilation by Magnetic Resonance Angiography Is Associated With Advanced Coronary Artery Calcification J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 167 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Burnett Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health J Androl, January 1, 2008; 29(1): 3 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stern Are We Getting Nearer to Screening for Atherosclerosis? Circulation, January 1, 2008; 117(1): 122 - 126. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans Hypertension, January 1, 2008; 51(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Versari, M. Gossl, D. Mannheim, E. Daghini, O. Galili, C. Napoli, L. O. Lerman, and A. Lerman Hypertension and Hypercholesterolemia Differentially Affect the Function and Structure of Pig Carotid Artery Hypertension, December 1, 2007; 50(6): 1063 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gomaraschi, D. Baldassarre, M. Amato, S. Eligini, P. Conca, C. R. Sirtori, G. Franceschini, and L. Calabresi Normal Vascular Function Despite Low Levels of High-Density Lipoprotein Cholesterol in Carriers of the Apolipoprotein A-IMilano Mutant Circulation, November 6, 2007; 116(19): 2165 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gossl, L. O. Lerman, and A. Lerman Frontiers in Nephrology: Early Atherosclerosis A View Beyond the Lumen J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2836 - 2842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Goligorsky Frontiers in Nephrology: Viewing the Kidney through the Heart Endothelial Dysfunction in Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2833 - 2835. [Full Text] [PDF]
|
|
|
|
|
|
M. Briet, C. Collin, S. Laurent, A. Tan, M. Azizi, M. Agharazii, X. Jeunemaitre, F. Alhenc-Gelas, and P. Boutouyrie Endothelial Function and Chronic Exposure to Air Pollution in Normal Male Subjects Hypertension, November 1, 2007; 50(5): 970 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lavi, J. P. McConnell, C. S. Rihal, A. Prasad, V. Mathew, L. O. Lerman, and A. Lerman Local Production of Lipoprotein-Associated Phospholipase A2 and Lysophosphatidylcholine in the Coronary Circulation: Association With Early Coronary Atherosclerosis and Endothelial Dysfunction in Humans Circulation, May 29, 2007; 115(21): 2715 - 2721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lavi, A. Prasad, E. H. Yang, V. Mathew, R. D. Simari, C. S. Rihal, L. O. Lerman, and A. Lerman Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease Circulation, May 22, 2007; 115(20): 2621 - 2627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Roquer, A. Ois, A. Rodriguez-Campello, M. Gomis, E. Munteis, J. Jimenez-Conde, E. Cuadrado-Godia, and J. E. Martinez-Rodriguez Atherosclerotic Burden and Early Mortality in Acute Ischemic Stroke Arch Neurol, May 1, 2007; 64(5): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Razvi, L. Ingoe, G. Keeka, C. Oates, C. McMillan, and J. U. Weaver The Beneficial Effect of L-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1715 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Shirodaria, C. Antoniades, J. Lee, C. E. Jackson, M. D. Robson, J. M. Francis, S. J. Moat, C. Ratnatunga, R. Pillai, H. Refsum, et al. Global Improvement of Vascular Function and Redox State With Low-Dose Folic Acid: Implications for Folate Therapy in Patients With Coronary Artery Disease Circulation, May 1, 2007; 115(17): 2262 - 2270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hattori, S. Hattori, X. Wang, H. Satoh, N. Nakanishi, and K. Kasai Oral Administration of Tetrahydrobiopterin Slows the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. O. Apostolov, A. G. Basnakian, X. Yin, E. Ok, and S. V. Shah Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1836 - H1846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-T. Kang, J. C. Sullivan, J. M. Sasser, J. D. Imig, and J. S. Pollock Novel Nitric Oxide Synthase-Dependent Mechanism of Vasorelaxation in Small Arteries From Hypertensive Rats Hypertension, April 1, 2007; 49(4): 893 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Chinen, M. Shimabukuro, K. Yamakawa, N. Higa, T. Matsuzaki, K. Noguchi, S. Ueda, M. Sakanashi, and N. Takasu Vascular Lipotoxicity: Endothelial Dysfunction via Fatty-Acid-Induced Reactive Oxygen Species Overproduction in Obese Zucker Diabetic Fatty Rats Endocrinology, January 1, 2007; 148(1): 160 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Napoli, L. O. Lerman, F. de Nigris, M. Gossl, M. L. Balestrieri, and A. Lerman Rethinking Primary Prevention of Atherosclerosis-Related Diseases Circulation, December 5, 2006; 114(23): 2517 - 2527. [Full Text] [PDF]
|
|
|
|
|
|
B. Cortes, I. Nunez, M. Cofan, R. Gilabert, A. Perez-Heras, E. Casals, R. Deulofeu, and E. Ros Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial Function J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1666 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Kern, A. Lerman, J.-W. Bech, B. De Bruyne, E. Eeckhout, W. F. Fearon, S. T. Higano, M. J. Lim, M. Meuwissen, J. J. Piek, et al. Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology Circulation, September 19, 2006; 114(12): 1321 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nohria, M. Gerhard-Herman, M. A. Creager, S. Hurley, D. Mitra, and P. Ganz Role of nitric oxide in the regulation of digital pulse volume amplitude in humans J Appl Physiol, August 1, 2006; 101(2): 545 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Gale, B. Jiang, S. M. Robinson, K. M. Godfrey, C. M. Law, and C. N. Martyn Maternal Diet During Pregnancy and Carotid Intima-Media Thickness in Children Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1877 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-d. Xiang, L. Xu, L.-s. Zhao, L. Yue, and J. Hou The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. Diabetes, July 1, 2006; 55(7): 2126 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ambrosius, R. Kazmierski, S. Michalak, and W. Kozubski Anti-inflammatory cytokines in subclinical carotid atherosclerosis Neurology, June 27, 2006; 66(12): 1946 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Viiri, O. T. Raitakari, H. Huhtala, M. Kahonen, R. Rontu, M. Juonala, N. Hutri-Kahonen, J. Marniemi, J. S. A. Viikari, P. J. Karhunen, et al. Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults J. Lipid Res., June 1, 2006; 47(6): 1298 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Lorkowska, M. Bartus, M. Franczyk, R. B. Kostogrys, J. Jawien, P. M. Pisulewski, and S. Chlopicki Hypercholesterolemia Does Not Alter Endothelial Function in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, J. E. Quigley, J. Yuan, M.-H. Wang, Y. Zhou, and J. D. Imig PPAR-{alpha} activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2187 - H2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. O'Brien, L. D. Serpero, R. Tauman, and D. Gozal Plasma adhesion molecules in children with sleep-disordered breathing. Chest, April 1, 2006; 129(4): 947 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Heistad Oxidative Stress and Vascular Disease: 2005 Duff Lecture Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 689 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali Endothelial Dysfunction and the Kidney: Emerging Risk Factors for Renal Insufficiency and Cardiovascular Outcomes in Essential Hypertension. J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S61 - S63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali, R. Maio, G. Tripepi, F. Mallamaci, and F. Perticone Inflammation as a Mediator of the Link between Mild to Moderate Renal Insufficiency and Endothelial Dysfunction in Essential Hypertension. J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S64 - S68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Quyyumi Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S66 - S71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, C. J. O'Donnell, G. H. Tofler, E. J. Benjamin, C. S. Fox, I. Lipinska, D. M. Nathan, L. M. Sullivan, R. B. D'Agostino, and P. W.F. Wilson Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes: The Framingham Offspring Study Diabetes, February 1, 2006; 55(2): 530 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. van der Harst, T. D.J. Smilde, H. Buikema, A. A. Voors, G. Navis, D. J. van Veldhuisen, and W. H. van Gilst Vascular Function and Mild Renal Impairment in Stable Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 379 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Rodrigues de Avila, J. L. Fernandes, C. E. Rochitte, G. G. Cerri, and J. P. Filho Perfusion Impairment in Patients with Normal-appearing Coronary Arteries: Identification with Contrast-enhanced MR Imaging Radiology, December 21, 2005; (2005) 2382041697. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Dickhout, G. S. Hossain, L. M. Pozza, J. Zhou, S. Lhotak, and R. C. Austin Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, F. Manguso, S. Savastano, T. Russo, A. Tolino, F. Zullo, G. Lombardi, et al. Improvement in Endothelial Structure and Function after Metformin Treatment in Young Normal-Weight Women with Polycystic Ovary Syndrome: Results of a 6-Month Study J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6072 - 6076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Amabile, A. P. Guerin, A. Leroyer, Z. Mallat, C. Nguyen, J. Boddaert, G. M. London, A. Tedgui, and C. M. Boulanger Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal Failure J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3381 - 3388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Caples, A. S. Gami, and V. K. Somers Obstructive Sleep Apnea Focus, October 1, 2005; 3(4): 557 - 567. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Chade, O. P. Mushin, X. Zhu, M. Rodriguez-Porcel, J. P. Grande, S. C. Textor, A. Lerman, and L. O. Lerman Pathways of Renal Fibrosis and Modulation of Matrix Turnover in Experimental Hypercholesterolemia Hypertension, October 1, 2005; 46(4): 772 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts J. Am. Coll. Cardiol., September 20, 2005; 46(6): 937 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF]
|
|
|
|